Non-licensed J&J vaccines began inoculation to health workers in South Africa

Syringe and Vial Illustration Against the South African Flag
Syringe and Vial Illustration Against the South African Flag

[로이터=연합뉴스 자료사진]

(Johannesburg = Yonhap News) Correspondent Kim Seong-jin = The Johnson & Johnson (J&J) novel coronavirus infection (Corona 19) vaccine, which has not yet been approved for use worldwide in South Africa, will be vaccinated in the form of research from health staff next week. I decided to do it.

South African Health Minister Zwelly Mkije announced in a statement on the 10th (local time) that “the Ministry of Health has decided to continue the first phase vaccination by using the J&J vaccine instead of the AstraZeneca (AZ) vaccine.”

“The J&J vaccine has proven to be effective against the 501Y.V2 mutant virus, and the necessary approval process for use in South Africa is in progress,” he said.

Accordingly, the J&J vaccine will be inoculated in the form of a priority study in cooperation with the South African Medical Research Council.

Minister Mkije said at a press conference that the vaccination would begin next week.

Among global clinical trials, Reuters reported that the J&J vaccine showed 89% efficacy in preventing severe diseases and 57% from moderate to severe in South Africa.

A syringe and vial with the Johnson & Johnson company logo in the background
A syringe and vial with the Johnson & Johnson company logo in the background

[로이터=연합뉴스 자료사진]

South Africa also secured a Pfizer vaccine for the first phase of vaccination.

“Our scientists are continuing to evaluate other vaccine candidates, and we are in contact with manufacturers at the same time,” said Zwelly. “We are in the advanced stages of evaluation of the Sputnik V vaccine candidate (from Russia), “We are also in contact with the manufacturer.”

He explained that consultations with Moder and Vaccines were underway, and that further announcements would be made when appropriate.

South Africa initially introduced 1 million doses of the AZ vaccine on the 1st through India’s Serum Institute (SII), but on the 7th announced that its efficacy against the South African mutant virus was limited, it halted distribution of the vaccine.

Minister Zwelly said, “The AZ vaccine (from South Africa) has been found to not prevent the mild and moderate severity of 501Y.V2 mutant disease.” The expiration date of the AZ vaccine introduced this time is April 30, so South African scientists He said he would further consider where to use the AZ vaccine.

He added that following their advice, the AZ vaccine would be exchanged before expiration so that it would not become obsolete or wasteful.

[email protected]

Source